Vulnerability Details : CVE-2011-4819
Multiple cross-site scripting (XSS) vulnerabilities in IBM Maximo Asset Management and Asset Management Essentials 6.2, 7.1, and 7.5 allow remote attackers to inject arbitrary web script or HTML via the uisesionid parameter to (1) maximo.jsp or (2) the default URI under ui/.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2011-4819
- cpe:2.3:a:ibm:maximo_asset_management:6.2:*:*:*:*:*:*:*
- cpe:2.3:a:ibm:maximo_asset_management:7.5:*:*:*:*:*:*:*
- cpe:2.3:a:ibm:maximo_asset_management:7.1:*:*:*:*:*:*:*
- cpe:2.3:a:ibm:maximo_asset_management_essentials:6.2:*:*:*:*:*:*:*
- cpe:2.3:a:ibm:maximo_asset_management_essentials:7.1:*:*:*:*:*:*:*
- cpe:2.3:a:ibm:maximo_asset_management_essentials:7.5:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2011-4819
0.30%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 50 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2011-4819
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
4.3
|
MEDIUM | AV:N/AC:M/Au:N/C:N/I:P/A:N |
8.6
|
2.9
|
NIST |
CWE ids for CVE-2011-4819
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by: nvd@nist.gov (Primary)
References for CVE-2011-4819
-
http://www-01.ibm.com/support/docview.wss?uid=swg1IV09202
IBM notice: The page you requested cannot be displayed
-
http://www.securityfocus.com/bid/52333
IBM Maximo Asset Management Multiple Security Vulnerabilities
-
http://www.ibm.com/support/docview.wss?uid=swg21584666
IBM Security Vulnerabilities Addressed in Asset and Service MgmtVendor Advisory
-
https://exchange.xforce.ibmcloud.com/vulnerabilities/72008
IBM Maximo Asset Management uisesionid parameter cross-site scripting CVE-2011-4819 Vulnerability Report
-
http://secunia.com/advisories/48299
Sign in
Jump to